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a b s t r a c t
The natural ﬂavonoid quercetin is known to activate the transcription factor Nrf2, which regulates the
expression of cytoprotective enzymes such as heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxido-
reductase 1 (NQO1). In this study, a novel semisynthetic ﬂavonoid 7-O-galloylquercetin (or quercetin-7-
gallate, 3) was prepared by direct galloylation of quercetin, and its effect on the Nrf2 pathway was
examined. A luciferase reporter assay showed that 7-O-galloylquercetin, like quercetin, signiﬁcantly
activated transcription via the antioxidant response element in a stably transfected human AREc32 re-
porter cell line. In addition, 7-O-galloylquercetin caused the accumulation of Nrf2 and induced the
expression of HO-1 at both the mRNA and protein levels in murine macrophage RAW264.7 cells. The
induction of HO-1 by 7-O-galloylquercetin was signiﬁcantly suppressed by N-acetyl-L-cysteine and
SB203580, indicating the involvement of reactive oxygen species and p38 mitogen-activated protein
kinase activity, respectively. HPLC/MS analyses also showed that 7-O-galloylquercetin was not degal-
loylated to quercetin, but it was conjugated with glucuronic acid and/or methylated in RAW264.7 cells.
Furthermore, 7-O-galloylquercetin was found to increase the protein levels of Nrf2 and HO-1, and also
the activity of NQO1 in murine hepatoma Hepa1c1c7 cells. Taken together, we conclude that 7-O-gal-
loylquercetin increases Nrf2 activity and induces Nrf2-dependent gene expression in RAW264.7 and
Hepa1c1c7 cells.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Natural ﬂavonoids are a large group of extensively studied plant
phenolic compounds. The basic ﬂavonoid structure consists of two
benzene rings (A and B) connected by three carbons that form an
oxygenated heterocycle (ring C). The ﬂavonoid skeletons such as
ﬂavone and ﬂavanone may bear different numbers of hydroxyl
groups, modiﬁcations of which can yield a multitude of compounds
[1]. The ﬂavonol quercetin (3,5,7,30,40-pentahydroxyﬂavone; Fig. 1),
arguably the most abundant and most studied bioﬂavonoid, is
predominantly found in plants in the form of its glycosides and
methyl ethers, such as rutin (quercetin-3-O-rutinoside), iso-
quercitrin (quercetin-3-O-b-D-glucoside) and isorhamnetin (30-O-
Abbreviations: ARE, antioxidant response element; DMSO, dimethyl sulfoxide;
ERK, extracellular signal-regulated kinase; Gapdh, glyceraldehyde-3-phosphate
dehydrogenase; GCLC, glutamate-cysteine ligase catalytic subunit; GCLM, gluta-
mate-cysteine ligase modiﬁer subunit; HO-1/Hmox1, heme oxygenase-1; JNK, c-Jun
N-terminal kinase; Keap1, Kelch-like ECH-associated protein 1; MAPK, mitogen-
activated protein kinase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide; NAC, N-acetyl-L-cysteine; NQO1, NAD(P)H:quinone
oxidoreductase 1; Nrf2, NF-E2 p45-related factor 2; p38 MAPK, p38 mitogen-
activated protein kinase; ROS, reactive oxygen species.
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methylquercetin) [2]. Naturally occurring conjugated forms of
quercetin also include those produced by the biotransformation
processes in the intestine and liver of animals and humans. The
main quercetin conjugates found in humanplasma are quercetin-3-
O-glucuronide, 30-O-methylquercetin-3-O-glucuronide and quer-
cetin-30-O-sulfate [3]. In addition, a number of quercetin de-
rivatives have been prepared in vitro using chemical or enzymatic
procedures. Some derivatives have been designed mainly with the
aim of improving the physico-chemical and biological properties of
quercetin, which is, despite its beneﬁcial (e.g. anti-inﬂammatory)
effects, unsuitable for medical applications due to low solubility
and low bioavailability [4]. Moreover, methods for the preparation
of quercetin metabolites have also been developed [5,6]. The
quercetin derivatives synthesized to date include, for instance, es-
ters of quercetin and of various aliphatic [7,8] and aromatic car-
boxylic acids [9e11], quercetin-amino acid conjugates with amino
acids attached to quercetin via a carbamate linkage [12], esters of
sulfuric acid (i.e. quercetin sulfates) [13,14], glycosides [15], glucu-
ronides [5], methyl ethers [16], etc.
One of the mechanisms mediating the beneﬁcial action of
quercetin is the activation of the transcription factor NF-E2 p45-
related factor 2 (Nrf2; also called NFE2L2) [17,18]. Nrf2 regulates
the expression of genes encoding various cytoprotective enzymes
such as heme oxygenase-1 (HO-1), NAD(P)H:quinone oxidoreduc-
tase 1 (NQO1), and glutamate-cysteine ligase catalytic (GCLC) and
modiﬁer subunits (GCLM) [19]. Being inspired by the fact that the
Nrf2 activation by catechins (ﬂavanols) positively depends on the
presence of a galloyl moiety in the molecule [20], we have previ-
ously prepared galloyl esters of quercetin and of its natural deriv-
ative, the ﬂavanonol taxifolin (2,3-dihydroquercetin), and
examined their effect on the Nrf2 pathway in murine macrophage
RAW264.7 cells. We have found that 3-O-galloylquercetin, in
contrast to quercetin, does not activate the Nrf2 pathway. On the
other hand, we have demonstrated the activation of Nrf2 in cells
treated with 7-O-galloyltaxifolin, while mere taxifolin was inactive.
The same study also found that 7-O-galloyltaxifolin was readily
oxidized to 7-O-galloylquercetin (Fig. 1) in RAW264.7 cells [11].
Since it was unclear which of these two molecules was responsible
for the biological response, we decided to prepare 7-O-galloyl-
quercetin and to investigate its effect on the Nrf2 pathway in vitro.
2. Experimental
2.1. General
NMR analyses were performed using a Bruker Avance III
600 MHz spectrometer (Bruker Biospin, Rheinstetten, Germany)
(600.23 MHz for 1H, 150.93 MHz for 13C) with samples dissolved in
DMSO-d6 (99.8% atom D; VWR International, Leuven, Belgium).
NMR spectra were referenced by the residual signal of the solvent
(dH 2.500 ppm, dC 39.60 ppm). NMR experiments, including 1H
NMR, 13C NMR, COSY, 1H-13C HSQC and 1H-13C HMBC, were per-
formed using the software Topspin3 (Bruker Biospin). The 1D
spectra, i.e. 1H NMR and 13C NMR spectra, were zero-ﬁlled to four-
fold data points prior to the Fourier transformation. Moreover, 1H
NMR data were multiplied by the two-parameter double-expo-
nential Lorentz-Gauss function to improve resolution, and line
broadening (1 Hz) was applied to the 13C NMR data to improve the
signal-to-noise ratio. Chemical shifts are listed in d-scale and
coupling constants in Hz. The digital resolution enabled us to
declare values to three (dH) or two (dC) decimal places. ESI-MS
spectra were measured with a Micromass LC-MS Platform in
MeOH with the addition of HCO2H; HRMS spectra (ESI, APCI, FAB)
weremeasuredwith an LTQ Orbitrap XL instrument (Thermo Fisher
Scientiﬁc, Waltham, MA, USA) or with a ZAB-EQ instrument (VG
Analytical, Manchester, UK).
2.2. Synthesis of 7-O-galloylquercetin (3)
3,4,5-Tri-O-benzylgallic acid (1 g, 2.5 mmol) was suspended in
dry dichloromethane (15 mL) under an argon atmosphere. Oxalyl
chloride (4 mL, 46.6 mmol) was added to the solution, and dry
dimethylformamide (2 mL, 26.0 mmol) was added to the resulting
mixture dropwise under stirring. After another 4 h of stirring, the
reaction mixture was diluted with dry toluene (5 mL) and evapo-
rated to dryness in vacuo. The resulting white crude 3,4,5-tri-O-
benzylgalloyl chloride was dissolved in dry pyridine (15 mL).
Quercetin (0.5 g, 1.65 mmol), previously dried by coevaporation
with dry toluene (90 C, 3  10 mL) in vacuo, was dissolved in dry
pyridine (5 mL). This solution was added to the cooled (60 C)
solution of 3,4,5-tri-O-benzylgalloyl chloride under an argon at-
mosphere and the reaction mixture was stirred overnight under
argon to slowly reach room temperature. Solvents were evaporated
and then coevaporated with toluene in vacuo to remove traces of
pyridine. The resulting solid wasmixedwith chloroform andwater;
the organic phase was separated, washed with water, dried with
Na2SO4 and evaporated to dryness. Flash chromatography on Sili-
cagel 60 (CHCl3/toluene/acetone/HCO2H, 85:5:5:1) yielded 7-O-
(30,40,50-tri-O-benzylgalloyl)quercetin (1; 260 mg, 27%) and 3-O-
(30,40,50-tri-O-benzylgalloyl)quercetin (2; 180 mg, 19%), which was
not used in further experiments.
1 (260 mg) was dissolved in EtOAc (20 mL), and then Pd/C
(150 mg, 10% Pd) was added and stirred under H2 for 3 h (20 C).
Palladium catalyst was then removed by ﬁltration through celite,
which was washed with acetone, and the solvent was evaporated.
The product was puriﬁed by gel ﬁltration (Sephadex LH-20, MeOH)
yielding 7-O-galloylquercetin (3; 180 mg, 89%). The purity (HPLC-
PDA) was 99.6%, HRMS (ESI) m/z [M  H]- calcd for C22H13O11
453.04524, found 453.04553 (for NMR data see Table S1 and
Figs. S2eS6, for HPLC see Fig. S7, for MS and HRMS see Figs. S8 and
S9 in Supplementary Information).
2.3. Reagents for biological testing
Quercetin, gallic acid methyl ester, hemin, sulforaphane, N-
acetyl-L-cysteine, PD98059 (2-(2-amino-3-methoxyphenyl)-4H-1-
Fig. 1. Chemical structures of tested compounds.
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benzopyran-4-one), SB203580 (4-(4-ﬂuorophenyl)-2-(4-
methylsulﬁnylphenyl)-5-(4-pyridyl)-1H-imidazole), SP600125
(1,9-pyrazoloanthrone), dimethyl sulfoxide (DMSO) and solvents
for HPLC were purchased from Sigma-Aldrich.
2.4. Cell cultures and treatments
The stable human mammary AREc32 reporter cell line [21] was
cultured in Dulbecco's modiﬁed Eagle's medium (DMEM; No.
41966, Gibco, Grand Island, NY, USA) supplemented with 2 mM
glutamine and 10% fetal bovine serum (FBS). The murine macro-
phage RAW264.7 cell line (No. 91062702, ECACC, Salisbury, UK) was
cultured in DMEM (D5796, Sigma) supplemented with 100 U/mL
penicillin, 100 mg/mL streptomycin and 10% FBS. The murine hep-
atoma Hepa1c1c7 cell line (No. 95090613, ECACC) was cultured in
Minimum essential medium a (M0894, Sigma) supplemented with
2.2 g/L NaHCO3 and 10% heat- and charcoal-treated FBS. Cells were
maintained at 37 C in a humidiﬁed atmosphere containing 5% CO2.
For experiments, cells were seeded into multiwell plates in serum-
containing medium. Experiments on AREc32 and Hepa1c1c7 cells
were performed after 24 h of stabilization in fresh serum-
containing medium. For RAW264.7 cells, the culture medium was
replaced with serum-free medium after 8 h of stabilization, and
following overnight incubation the experiments were performed in
fresh serum-free conditions. Cells were treated with the tested
compounds (in 0.1% (v/v) DMSO) and negative controls were
treated with 0.1% DMSO alone.
2.5. Cell viability assay
RAW264.7 cells (1.7  105 cells/well in a 24-well plate) and
Hepa1c1c7 cells (1  104 cells/well in a 96-well plate) were treated
for 6 or 48 h, respectively, with 0.1% DMSO (control), 1.5% (v/v)
Triton X-100 (positive control) or with the tested compounds. After
treatment, the cell viability was determined using the MTT reduc-
tion assay. Cells werewashed with phosphate-buffered saline (PBS)
and incubated for 2 h at 37 C in fresh serum-free medium con-
taining 0.5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT). After this, the medium was
removed and formazan produced by active mitochondria was dis-
solved in DMSO. The absorbance at 540 nm was measured on a
spectrophotometric plate reader and used to calculate relative cell
viability, where cells treated with DMSO alone represented 100%
viability.
2.6. Gene reporter assay
AREc32 cells were seeded into a 96-well plate at 1  104 cells/
well. On the next day, cells were exposed for 24 h to the tested
compounds. Afterwards, the plate was frozen at20 C for 24 h and
then the luciferase activity was measured on a GloMax-
Multiþ microplate luminometer (Promega, Madison, WI, USA) us-
ing the Bright-Glo Luciferase Assay System (Promega). The lumi-
nescence values were normalized to the protein content of the cells
and used for calculation of fold changes versus the control.
2.7. Reverse transcription and quantitative real-time PCR
After the treatment of RAW264.7 cells (8  105 cells/well in a 6-
well plate), total RNA was extracted using TRI Reagent Solution
(Applied Biosystems, Foster City, CA, USA). RNA samples (2 mg) were
reverse transcribed using a High-Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems) and real-time PCR was per-
formed in a LightCycler 480 II system (Roche Diagnostics,
Mannheim, Germany) using TaqMan Universal PCRMaster Mix and
TaqMan Gene Expression Assays, consisting of speciﬁc primers and
FAM dye-labeled TaqMan minor groove binder probes (Applied
Biosystems). The assay ID was Mm00516005_m1 for Hmox1 and
Mm99999915_g1 for Gapdh. Ampliﬁcation conditions were 50 C
for 2 min, 95 C for 10 min, followed by 40 cycles at 95 C for 15 s
and 60 C for 1 min. Crossing point values, equivalent to CT, were
determined using second derivative maximum analysis. Relative
changes in gene expression were calculated by the comparative CT
method using the 2DDCT equation with results normalized to
Gapdh mRNA levels.
2.8. Western blot analysis
After the treatment of RAW264.7 cells (8  105 cells/well in a 6-
well plate) or Hepa1c1c7 cells (4  105 cells/well in a 6-well plate),
total cellular extracts were prepared as described previously [11].
Aliquots containing an equal amount of protein were subjected to
electrophoresis through 4e12% sodium dodecyl sulfate-
polyacrylamide gel, proteins were transferred to polyvinylidene
diﬂuoride membrane by electroblotting, and the membranes were
probed with appropriate primary antibodies. Rabbit polyclonal
heme oxygenase-1 (sc-10789), rabbit polyclonal Nrf2 (sc-722), goat
polyclonal Keap1 (sc-15246) and goat polyclonal actin (sc-1616)
antibodies were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Antibodies against NQO1, GCLC and GCLM were
kindly provided by Dr. John D. Hayes (University of Dundee, Dun-
dee, UK). Primary antibodies were visualized with rabbit anti-goat
or goat anti-rabbit horseradish peroxidase-conjugated secondary
antibodies using a chemiluminescent reaction.
2.9. HPLC/MS analysis of biotransformation products
RAW264.7 cells (8  105 cells/well in a 6-well plate) were
incubated for 0e6 h with 15 mM 7-O-galloylquercetin. After incu-
bation, cells were scraped from the plates, collected by gentle
centrifugation, washed twice with PBS, resuspended in 0.4 mL of
methanol containing 5% (v/v) acetic acid, and sonicated 10 times at
50% amplitudewith a cycle set at 0.5 s using an Ultrasonic Processor
UP200s equipped with a Sonotrode Microtip S2 sonicator probe
(Hielscher, Teltow, Germany). Afterwards, the cell lysates were
centrifuged for 2 min at 14 000 g at room temperature and the
supernatants were analyzed by HPLC/MS. Aliquots of culture me-
dium were diluted (1:1, v/v) in methanol containing 5% (v/v) acetic
acid, centrifuged for 2 min at 14 000 g and the supernatants were
analyzed by HPLC/MS. The chromatographic separation was per-
formed in an Agilent Zorbax Eclipse XDB-phenyl column
(150 mm  2.1 mm i.d., 5 mm; Agilent Technologies, CA, USA) using
an Acquity UPLC system (Waters, Milford, MA, USA) equipped with
a binary solvent manager, sample manager, column manager and
photodiode array detector. A Waters QqTof Premier Mass Spec-
trometer (Waters, Manchester, UK) was connected to the UPLC
systemvia an electrospray ionization (ESI) interface. Acquiring data
enabled the collection of intact precursor ions as well as fragment
ion information in an unbiasedmanner. Post-acquisition processing
of the data was performed using Metabolynx V4.1 software (Wa-
ters, Milford, MA, USA). For more details, see Ref. [22].
2.10. NQO1 activity assay
After the treatment of Hepa1c1c7 cells (1  104 cells/well in a
96-well plate), the activity of NQO1 was determined spectropho-
tometrically as described previously [23]. Cells were washed four
times with PBS and lysed with 75 mL of digitonin solution (0.8 g/L
digitonin, 2 mM EDTA, pH 7.8) by shaking on an orbital shaker for
20 min at room temperature. One part of the cell lysate (20 mL) was
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used to determine the protein content. The remaining lysate (55 mL)
was mixed with 200 mL of 0.5 M Tris-Cl buffer containing 10%
bovine serum albumin, 1.5% Tween-20, 7.5 mM FAD, 150 mM
glucose-6-phosphate, 2 U/mL glucose-6-phosphate dehydrogenase
(Roche), 50 mM NADPþ, 25 mM menadione and 0.7 mM MTT. The
mixture was incubated for 5 min at room temperature and the
reaction was stopped with 50 mL of dicumarol solution (0.3 mM
dicumarol, 5 mM potassium phosphate, 0.5% DMSO). The absor-
bance of the reduced MTT corresponding to the activity of NQO1
was measured at 610 nm on a spectrophotometric plate reader. The
absorbance values were normalized to the protein content of the
cells and used for the calculation of fold changes versus the control.
2.11. Statistical analysis
Results were expressed as means ± standard deviation (SD). The
differences in mean values were analyzed by one-way ANOVAwith
Tukey's post hoc test. A p value of less than 0.05 was considered to
be statistically signiﬁcant.
3. Results and discussion
3.1. Synthesis of 7-O-galloylquercetin (3)
The synthesis of 3 was performed by direct galloylation of
quercetin with 3,4,5-tri-O-benzylgalloyl chloride in pyridine
(Scheme 1). 3,4,5-Tri-O-benzylgalloyl chloride in pyridine was
prepared by treating tribenzylgallic acid with oxalyl chloride so-
lution in CH2Cl2 and a catalytic amount of dimethylformamide
immediately before use. The reaction yielded two regioisomers 1
and 2 that were separated by ﬂash chromatography. Benzyl-
protected intermediate 1 was then deprotected by catalytic
hydrogenolysis catalyzed with Pd/C, giving the ﬁnal galloyl ester 3.
3.2. Effect of 7-O-galloylquercetin (3) on cell viability
The aim of the biological part of the study was to investigate
whether 3 activates the Nrf2 pathway. For that purpose, we used
three cell models including murine macrophage RAW264.7 cells,
murine hepatoma Hepa1c1c7 cells, and stably transfected AREc32
reporter cells derived from human breast cancer MCF7 cells [21]. To
compare the effect of 3with those of its structural components, we
also included quercetin and gallic acid methyl ester (methyl gallate)
in our experiments (Fig.1).Methyl gallatewas chosen instead of free
gallic acid, since the acid was previously shown to have only aweak
stimulating effect on the Nrf2 pathway [11]. In this study, we tested
both 3 and its structural components at concentrations of up to
15 mM. At these concentrations, the tested compounds had a weak
or negligible effect on the viability of cells used. We found that 3
only decreased cell viability below 90% in RAW264.7 cells, and this
effect was comparable to that of quercetin. As shown by the MTT
reduction assay, the viability of RAW264.7 cells treated for 6 h with
15 mM 3 or quercetinwas 80% and 86%, respectively. The effect of the
tested compounds on the viability of RAW264.7 and Hepa1c1c7
cells after 6 and 48 h of incubation, respectively, is shown in Fig. 2.
3.3. Activation of Nrf2 by 7-O-galloylquercetin (3) in AREc32
reporter cells
To evaluate the effect on the Nrf2 pathway, we ﬁrst examined
whether compound 3 and its structural components could induce
the transcriptional activity of Nrf2 in the stably transfected human
AREc32 reporter cell line. AREc32 cells contain a luciferase reporter
gene controlled by eight copies of the antioxidant response element
(ARE), through which Nrf2 activates the expression of its target
genes [21]. The treatment of AREc32 cells for 24 h with 5 mM sulfo-
raphane, used as a positive control [21], resulted in an 8.2-fold in-
crease in luciferase activity compared to the control (Fig. 3). A
signiﬁcant increase in luciferase activity was also induced by 3 and
quercetin, with the latter compound being more effective. In
contrast, a mild or negligible elevation in luciferase activity was
detected after cell exposure to methyl gallate. After 24 h of incuba-
tion, the activity of luciferase reached 4.4-fold, 1.8-fold and 1.3-fold
in cells treated with 15 mM quercetin, 3 and methyl gallate, respec-
tively (Fig. 3). These results demonstrated that 3 activates the Nrf2-
dependent transcription, albeitwitha lowerpotency thanquercetin.
3.4. Induction of HO-1 by 7-O-galloylquercetin (3) in
RAW264.7 cells
The study further compared the effect of 3 and its structural
components on the expression of HO-1 in RAW264.7 cells. HO-1,
Scheme 1. Synthesis of 7-O-galloylquercetin (3).
Reagents and conditions: (a) 3,4,5-tri-O-benzylgalloyl chloride (1.5 equiv), pyridine, e60 C, 1 h, 27%; (b) H2ePd/C, EtOAc, room temp, 3 h, 89%.
Fig. 2. Effect of tested compounds on viability of RAW264.7 and Hepa1c1c7 cells.
RAW264.7 and Hepa1c1c7 cells were treated for 6 or 48 h (as indicated) with 0.1%
DMSO (control), 15 mM quercetin (QUE) or with 3.75e15 mM 7-O-galloylquercetin (3) or
methyl gallate (MG). The cell viability was determined by the MTT reduction assay. Data
are means ± SD of three experiments. *p < 0.05, signiﬁcantly decreased versus control.
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encoded by the Hmox1 gene, is an inducible form of heme oxygen-
ase, an enzyme that degrades heme to Fe2þ, the antioxidant bili-
verdin and anti-inﬂammatory agent carbon monoxide [24]. As
shown by quantitative real-time PCR, the treatment of
RAW264.7 cells for 6 h with 5 mM hemin, a positive control, signif-
icantly increased the level of Hmox1 mRNA to 53-fold when
normalized to Gapdh mRNA (Fig. 4A). After 6 h of incubation, 3was
found to induce the expression of theHmox1 gene in RAW264.7 cells
in a dose-dependent manner, with a signiﬁcant increase in Hmox1
mRNA detected at concentrations from 7.5 mM. The levels of Hmox1
mRNAwere also elevated in cells treatedwith quercetin andmethyl
gallate, but their effect was weaker than that of 3. At the concen-
tration of 15 mM, Hmox1 mRNA levels induced by 3, quercetin and
methyl gallate reached 7.9-fold, 3.0-fold and 2.0-fold, respectively,
compared to the control (Fig. 4A).Western blot analysis showed that
the induction of Hmox1 gene expression by 3 was also associated
with the upregulation of the HO-1 protein. After 6 h of cell exposure
to 3, the highest level of HO-1 was found at the concentration of
7.5 mM.We also found that quercetin (15 mM) upregulated HO-1 to a
level comparable to that induced by 3, whereas methyl gallate
produced lower levels of HO-1 (Fig. 4B). It should bementioned that
the induction of HO-1 in RAW264.7 cells by quercetin was reported
previously [11,25] and the ability ofmethyl gallate toupregulateHO-
1 was demonstrated in mouse mesangial cells [26].
The expression of the Hmox1 gene is regulated by Nrf2. Under
unstressed conditions, Nrf2 is targeted for proteasomal degradation
through its interactionwith the repressor protein Keap1 (Kelch-like
ECH-associated protein 1). Conversely, stress conditionsmay impair
the interaction between Nrf2 and Keap1 via the phosphorylation of
Fig. 3. 7-O-Galloylquercetin (3) induces ARE-driven gene expression. AREc32 reporter
cells were treated for 24 h with 0.1% DMSO (control), 5 mM sulforaphane (SFN; positive
control) or with 3.75e15 mM 3, quercetin (QUE) or methyl gallate (MG). After treat-
ment, luciferase reporter activity was determined luminometrically and normalized to
protein content. Data are means ± SD of three experiments. *p < 0.05; **p < 0.01,
signiﬁcantly increased versus control.
Fig. 4. 7-O-Galloylquercetin (3) induces HO-1 expression and Nrf2 accumulation in
RAW264.7 cells. Cells were treated for 6 h with 0.1% DMSO (control), 5 mM hemin (HM;
positive control), 15 mM quercetin (QUE) or with 3.75e15 mM 3 or methyl gallate (MG).
(A) After treatment, relative changes in Hmox1 mRNA levels were determined by
quantitative real-time PCR with results normalized to Gapdh mRNA. Data are
means ± SD of ﬁve experiments. *p < 0.05; **p < 0.01, signiﬁcantly increased versus
control. (B) After treatment, protein levels of HO-1, Nrf2, Keap1 and actin in the whole
cell lysates (20 mg/lane) were analyzed by Western blotting. Representative Western
blots are shown.
Fig. 5. Effect of MAPK inhibitors and N-acetyl-L-cysteine (NAC) on 7-O-galloylquercetin
(compound 3)-induced Hmox1 gene expression in RAW264.7 cells. (A) Cells were
pretreated for 30 min with 0.1% DMSO (control), 15 mM PD98059, 15 mM SB203580 or
30 mM SP600125 and then incubated in the absence or presence of 15 mM 3 for an
additional 6 h. (B) Cells were pretreated for 30 min with 2.5 or 5 mM NAC and then
incubated in the absence or presence of 15 mM 3 for an additional 6 h. The levels of
Hmox1 mRNA were determined by quantitative real-time PCR and normalized to
Gapdh mRNA. Results are expressed as the percentage of compound 3-induced Hmox1
mRNA expression. Data are means ± SD of three experiments. **p < 0.01, signiﬁcantly
decreased versus 3 in the absence of MAPK inhibitors or NAC.
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Nrf2 or through the oxidation or covalent modiﬁcation of Keap1,
which in turn undergoes proteasomal degradation. The disruption
of the Keap1eNrf2 interaction results in the accumulation of Nrf2
and its translocation to the nucleus, where it binds to the DNA at the
ARE and triggers the expression of Nrf2 target genes [27,28].
Accordingly, the Western blot analysis showed that 5 mM hemin
increased the level of Nrf2 and concurrently decreased the level of
Keap1 in RAW264.7 cells after 6 h of incubation (Fig. 4B). We found
that 3 at a concentration of 15 mM also upregulated Nrf2, but the
level of Keap1 remained unchanged after 6 h of exposure. Similarly,
quercetin and methyl gallate also increased Nrf2 without affecting
Keap1 levels (Fig. 4B). The accumulation of Nrf2 together with the
induction of HO-1 indicates that 3, like quercetin, may activate the
Nrf2 pathway in RAW264.7 cells.
3.5. Induction of HO-1 by 7-O-galloylquercetin (3) involves ROS
and p38 MAPK activity
As described above, the accumulation of Nrf2 in RAW264.7 cells
by compound 3was not associatedwith a downregulation of Keap1.
Since the activation of Nrf2 may also be mediated through its
phosphorylation [28], we investigated, using pharmacological in-
hibitors, whether mitogen-activated protein kinases (MAPKs)
including p38 MAPKs, extracellular signal-regulated kinases
(ERKs), and c-Jun N-terminal kinases (JNKs) could play a role in the
cell response to 3. We found that the increase in Hmox1 mRNA
induced by 3 was reduced signiﬁcantly by the p38 MAPK inhibitor
SB203580, and nonsigniﬁcantly by the ERK inhibitor PD98059
(Fig. 5A). Pretreatment of RAW264.7 cells for 30 min with 15 mM
SB203580 or 15 mM PD98059 decreased the induction of Hmox1
mRNA by 6 h of exposure to 15 mM 3 by 71% and 15%, respectively.
On the other hand, cell pretreatment with 30 mM SP600125, a JNK
inhibitor, potentiated the effect of 3 on Hmox1mRNA expression by
181% under the same experimental conditions (Fig. 5A).
The MAPK pathways may be activated by various stimuli
including reactive oxygen species (ROS) [29]. As shown in Fig. 5B,
the elevation in Hmox1 mRNA induced in RAW264.7 cells by 3 was
signiﬁcantly suppressed by N-acetyl-L-cysteine (NAC), a nonspeciﬁc
ROS scavenger. For instance, 30 min of the cell pretreatment with
2.5 mM NAC decreased the induction of Hmox1 mRNA by 6 h of
exposure to 15 mM 3 by 69% (Fig. 5B). These results suggest that the
activation of Nrf2 by 3 is mediated through the enhanced produc-
tion of ROS and activation of p38 MAPKs. As shown in our previous
study [11], both of these events were also involved in HO-1 induc-
tion in RAW264.7 cells exposed to 7-O-galloyltaxifolin, which only
differs from 3 in the absence of a 2,3-double bond. Taking into ac-
count the oxidation of 7-O-galloyltaxifolin to 3 [11] and essentially
the samemechanism of HO-1 induction found for both compounds,
it may be supposed that compound 3 was responsible for the bio-
logical effect of 7-O-galloyltaxifolin in RAW264.7 cells [11].
3.6. Uptake and biotransformation of 7-O-galloylquercetin (3) by
RAW264.7 cells
The study also investigated the metabolic fate of 3 in
RAW264.7 cells. The cells were incubated for up to 6 h with 15 mM 3,
and the cells and culture mediumwere separately analyzed using the
previously developed high-performance liquid chromatography-
mass spectrometry (HPLC/MS) method in Ref. [22]. As recorded with
an ESI-MS detector operating in negative mode, compound 3 gave a
well-resolved chromatographic peak at a tR of 14.6 min (Fig. 6A). We
found that during the incubation period, the concentration of 3 in the
culturemediumevidently decreased. In contrast, the concentration of
3 in cell extracts increased at the beginning of the incubation, reached
a maximum at 2 h and then a decline in the concentration occurred
(Fig. 6B). These ﬁndings indicated that 3 was absorbed by
RAW264.7 cells and that the galloyl ester underwent some kind of
metabolic transformation and/or degradation. Analyses showed that
compound 3was stable in terms of possible hydrolytic cleavage, since
no signiﬁcant amounts of quercetin and gallic acid were detected in
either the cells or medium (Fig. 6B). Thus, we could rule out the
possibility that the biological effects of 3were mediated by its struc-
tural components. Furthermore,we found that 3wasnot converted to
7-O-galloyltaxifolin. On the other hand, two types of phase II
Fig. 6. Biotransformation and uptake of 7-O-galloylquercetin (3) by RAW264.7 cells. Cells were treated for 0e6 h with 15 mM 3 or 0.1% DMSO (control), and cell extracts and culture
mediumwere analyzed by HPLC with negative ESI-MS detection. (A) HPLC/MS chromatograms of 3 (inset) and of its metabolites found in cells after 2 h of treatment. (B) Time course
of distribution of 3, quercetin (QUE) and gallic acid (GA) in cells and medium. Data are means ± SD of three experiments.
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conjugation reactions, i.e. glucuronidation andmethylation, appeared
to be involved in the transformation of 3 in RAW264.7 cells. Analyses
revealed three different glucuronides of the parent compound eluted
at tR of 12.7, 13.1 and 14.4 min, a methyl derivative eluted at a tR of
15.8min, and also amethylated glucuronide that appeared as aminor
metabolite at a tR of 13.6min (Fig. 6A). The full and fragmentationMS
spectraof3andof itsmetabolites are shown inFig. 7.Wewerenot able
to identify which hydroxyl groups in the molecule of 3 were conju-
gated. Nonetheless, some of the conjugations could occur at the same
positions which are conjugated in quercetin and gallic acid metabo-
lites such as 30-O-methylquercetin-3-O-glucuronide [3] and 4-O-
methylgallic acid [30]. Themetabolic activityof RAW264.7 cellswas in
accordance with the study showing the methylation of quercetin in
this cell line [31]. Moreover, the expression of UDP-
glucuronosyltransferases was reported in macrophages [32]. It
might be mentioned that we previously showed the formation of
glucuronides and methyl derivatives of 3-O-galloylquercetin in hu-
man hepatocytes [22]. Hence, it may be supposed that the biotrans-
formationpatternof3 found inRAW264.7cells canalsobeexpected in
other cell types expressing the phase II conjugating enzymes.
3.7. Induction of NQO1 activity by 7-O-galloylquercetin (3) in
Hepa1c1c7 cells
To evaluate whether 3 could stimulate the Nrf2 pathway in cells
other than macrophages, we tested the effect of the compound on
Fig. 7. Full and fragmentation (insets) MS spectra of 7-O-galloylquercetin (3) and of its metabolites. The MS spectra were obtained from the chromatographic peaks shown in Fig. 6.
(A) Parent compound 3, m/z 453, (B) glucuronide of 3, tR 13.1 min, m/z 629 (C) methylated 3, m/z 467, (D) methylated and glucuronidated 3, m/z 643.
Fig. 8. 7-O-Galloylquercetin (3) induces NQO1 activity and Nrf2 accumulation in Hepa1c1c7 cells. (A) Cells were treated for 48 h with 0.1% DMSO (control), 5 mM sulforaphane (SFN;
positive control) or with 3.75e15 mM 3, quercetin (QUE) or methyl gallate (MG). After treatment, the activity of NQO1 was determined using the NQO1 assay. Data are means ± SD of
three experiments. *p < 0.05; **p < 0.01, signiﬁcantly increased versus control. (B) Cells were treated for 3 or 24 h (as indicated) with 0.1% DMSO (control), 5 mM sulforaphane (SFN;
positive control) or with 15 mM 3, quercetin (QUE) or methyl gallate (MG). After treatment, the protein levels of Nrf2, NQO1, HO-1, GCLC, GCLM, and actin in the whole cell lysates
(30 mg/lane) were analyzed in duplicate by Western blotting. Representative Western blots are shown.
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murine hepatoma Hepa1c1c7 cells, a well-established model for
the identiﬁcation of possible NQO1 inducers [23]. The NQO1 assay
showed that the treatment of Hepa1c1c7 cells for 48 h with 5 mM
sulforaphane, a positive control [23], elevated the activity of NQO1
3.7-fold compared to the control (Fig. 8A). The induction of NQO1
activity by sulforaphane was accompanied by an obvious increase
in the levels of Nrf2 and Nrf2-regulated proteins, namely, NQO1,
HO-1, GCLC and GCLM, as demonstrated by Western blot analysis
after 3 and/or 24 h of exposure (Fig. 8B). We found that the activity
of NQO1 in Hepa1c1c7 cells was also elevated by 3 and quercetin,
but not by methyl gallate. However, 3 signiﬁcantly increased NQO1
activity only at the highest concentration tested, thus it was a less
effective NQO1 inducer than quercetin. In cells treated for 48 hwith
15 mMquercetin, 3 andmethyl gallate, the activity of NQO1 reached
2.1-fold, 1.8-fold and 0.9-fold, respectively, compared to the control
(Fig. 8A). In Hepa1c1c7 cells, 3 (15 mM) was also found to induce a
mild increase in the protein levels of Nrf2, HO-1 and GCLM after
24 h of incubation, while the levels of NQO1 and GCLC were un-
affected. Quercetin (15 mM) clearly elevated Nrf2 as early as after 3 h
of exposure and upregulated NQO1 and GCLM, but not HO-1 and
GCLC after 24 h. In contrast, no substantial changes in the levels of
Nrf2 and Nrf2-regulated proteins were detected in cells treated
with methyl gallate (Fig. 8B). Our results show that the ability of 3
to stimulate the Nrf2 pathway is not restricted to one cell type. The
potency of 3 compared to that of quercetin seems, however, to
depend on the cell model used.
4. Conclusions
The novel semisynthetic ﬂavonoid 7-O-galloylquercetin (3) has
been prepared by the direct galloylation of quercetin. We have
demonstrated that 3, like quercetin, activates the Nrf2 pathway
in vitro. This is supported by the ﬁndings that 3 i) activates the
antioxidant response element in AREc32 reporter cells, ii) induces
the accumulation of Nrf2 in RAW264.7 and Hepa1c1c7 cells, iii)
induces the expression of HO-1 at both the mRNA and protein
levels in RAW264.7 cells, and iv) increases the activity of NQO1 and
protein levels of HO-1 and GCLM in Hepa1c1c7 cells. We have also
shown in RAW264.7 cells that the activation of the Nrf2 pathway by
3 involves ROS and p38 MAPK activity, and is not accompanied by
the degalloylation of 3 to quercetin. In addition, we have demon-
strated that macrophages may contribute to the metabolism of
galloylated ﬂavonoids, since 3 was glucuronidated and/or methyl-
ated in RAW264.7 cells.
Our results suggest that the galloyl ester 3 is a somewhat less
potent activator of Nrf2 than quercetin. Nonetheless, we can
speculate that the galloylation also affects other properties relevant
to its potential application, such as water-solubility, stability and
membrane permeability. This aside, the overall biological activity of
3may depend, for instance, on the interactions of the galloyl group
with ROS [33], transition metal ions [34,35] and proteins [1]. In
conclusion, since Nrf2 plays a crucial role in the maintenance of
cellular redox homeostasis, we suggest that further research on
compound 3 could be aimed at evaluating its protective potential
against oxidative stress induced in vitro and/or in vivo.
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